Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of BPMC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Blueprint Medicines Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 8.00%5.09M shares | – | Apr 23, 20251 filing | Apr 23, 2025 | SEC |
| Pentwater Capital Management LP | 13G | 6.00%3.90M shares | New | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on Blueprint Medicines Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20254:10 PM ET | Pentwater Capital Management LPand 1 other | 13G | 6.00%3.90M shares | New | Jun 30, 2025 | SEC |
| Aug 14, 20251:07 PM ET | Price T Rowe Associates Inc | 13G/A | 2.30%1.47M shares | –Below 5% | Jun 30, 2025 | SEC |
| Aug 14, 20257:18 AM ET | Avoro Capital Advisors LLCand 1 other | 13G/A | 0.60%375.0K shares | −5.40 ppfrom 6.00%Below 5% | Jun 30, 2025 | SEC |
| Jul 21, 20254:15 PM ET | Davidson Kempner Capital Management LPand 3 others | 13G | 0.00%0 shares | NewBelow 5% | Jul 14, 2025 | SEC |
| May 15, 20259:30 AM ET | Avoro Capital Advisors LLCand 1 other | 13G | 6.00%3.85M shares | New | Mar 31, 2025 | SEC |
| May 12, 202510:44 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 4.80%3.07M shares | –Below 5% | Mar 31, 2025 | SEC |
| Apr 23, 20258:19 PM ET | BlackRock, Inc. | 13G/A | 8.00%5.09M shares | – | Mar 31, 2025 | SEC |
| Feb 12, 20259:16 AM ET | FMR LLCand 1 other | 13G/A | 3.50%2.25M shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Blueprint Medicines Corp shares.
No Form 144 notices for Blueprint Medicines Corp are on file.